Nova Biomedical | Finanzwire

Basculer en Français

10767	Companies
231802	Keywords
160244	Articles
123319	Press releases

Home
Companies
Nova Biomedical

BRIEF

published on 07/24/2026 at 16:05, 3 hours 3 minutes ago

Nova Biomedical Expands with NanoCellect Acquisition

Biopharmaceutical Mergers & Acquisitions Cell Line Development Microfluidic Technology Clone Selection
PRESS RELEASE

published on 07/24/2026 at 16:00, 3 hours 8 minutes ago

Nova Biomedical Advances Integrated Cell Line Development Workflows: NanoCellect products are now part of Nova Biomedical
Nova Biomedical acquires NanoCellect, expanding cell line development capabilities and enhancing biopharmaceutical workflows. Integration of technologies to optimize clone selection and manufacturing processes

Biopharmaceutical Workflow Cell Line Development Nova Biomedical NanoCellect

Accesswire

Published on 07/24/2026 at 14:00, 5 hours 8 minutes ago

NanoViricides Announces Pricing of ~$3.8 Million Registered Direct Offering
Published on 07/24/2026 at 13:10, 5 hours 58 minutes ago

Spirit Blockchain Capital Appoints Suha Askary as Chief Executive Officer
Published on 07/24/2026 at 09:10, 9 hours 58 minutes ago

HM Exploration Commences Optical & Acoustic Televiewer Program at the Lewis Pilley's Project
Published on 07/24/2026 at 08:00, 11 hours 8 minutes ago

Galantas Announces Amendment to a Dragones Share Purchase Agreement
Published on 07/24/2026 at 05:55, 13 hours 13 minutes ago

Alphinat Announces a Loss of $(44,521) for Quarter Ended May 31, 2026

View all ACCESSWIRE

EQS Group

Published on 07/24/2026 at 18:44, 23 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 07/24/2026 at 17:50, 1 hour 18 minutes ago

Fuller, Smith & Turner PLC: Director / PDMR Shareholding
Published on 07/24/2026 at 17:40, 1 hour 28 minutes ago

2CRSi SA: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital as of May 31, 2026.
Published on 07/24/2026 at 16:23, 2 hours 45 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 07/24/2026 at 16:22, 2 hours 46 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc

Les Echos

Published on 07/24/2026 at 18:50, 17 minutes ago

Disclosure of transactions in own shares from July 20 to July 24, 2026
Published on 07/24/2026 at 18:11, 56 minutes ago

H1 2026 liquidity contract statement for TF1
Published on 07/24/2026 at 18:06, 1 hour 2 minutes ago

TF1 First-Half 2026 Financial Report
Published on 07/24/2026 at 18:00, 1 hour 7 minutes ago

TF1 H1 2026 results - Press release
Published on 07/24/2026 at 08:00, 11 hours 8 minutes ago

Accor signs a definitive binding agreement on the sale of its stake in Essendi

View all LES ECHOS COMFI WIRE